Latest / PETRI DISH PERSPECTIVES
Episode 49: AI in Pharma / Biotech
Send us Fan Mail
In this episode, we explore the high-stakes reality of AI integration in the life sciences. We move past the speculative hype to examine the mechanical necessity of this shift, driven by soaring R&D costs and an explosion of biological data, and how the industry has transitioned from a "serendipity-based" model to one of predictive, generative biology.
We break down the leaders of this revolution, comparing the "TechBio" pioneers like Insilico and Recursion with the massive infrastructure bets currently being made by Big Pharma giants. From the rise of autonomous…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.